Stock listing

NASDAQ:RAIN Rain Oncology Inc Stock

Follow Rain Oncology Inc into a list and get an email when it puts out news.

Last close · NASDAQ:RAIN

$1.21 USD

Close on Jan 26, 2024 · No longer trades

Apr 23, 2021 to last close -92.3% · weekly closes, Apr 23, 2021 – Jan 26, 2024
Lowest – highest close
$0.822 – $20.91 USDSince Apr 23, 2021 · lowest Sep 15, 2023 · highest Jul 12, 2021

Delisted NASDAQ:RAIN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:RAIN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Events

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 16, 2026+41.3%
Quarter to Jun 30, 2026Aug 14, 2026−9.2%
Quarter to Sep 30, 2025Nov 13, 2025+18.1%
Quarter to Jun 30, 2025Aug 14, 2025−6.3%
Quarter to Mar 31, 2025May 15, 2025+19.2%
Quarter to Mar 31, 2024May 21, 2024
Quarter to Dec 31, 2023Feb 29, 2024
Quarter to Sep 30, 2023Nov 9, 2023
Quarter to Jun 30, 2023Aug 10, 2023
Quarter to Mar 31, 2023May 11, 2023
All 18 quarters
QuarterResultsShare move
Quarter to Dec 31, 2022Mar 9, 2023
Quarter to Sep 30, 2022Nov 10, 2022
Quarter to Jun 30, 2022Aug 4, 2022
Quarter to Mar 31, 2022May 4, 2022
Quarter to Dec 31, 2021Mar 3, 2022
Quarter to Sep 30, 2021Nov 10, 2021
Quarter to Jun 30, 2021Aug 10, 2021
Quarter to Mar 31, 2021Apr 2, 2021

Open Events

Cap table

Built by 6ix from Rain Oncology Inc’s releases

Common shares
11,646,299
Fully diluted
11,646,299

Fully diluted

LineShares
Common shares11,646,299

Share count over time

CountShares
Nov 22, 202611,646,299

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Franklin Berger
Other companies: Retension Pharmaceuticals, Inc. (Director · Since at least Oct 13, 2026); Atea Pharmaceuticals, Inc. (Director · Since at least Oct 29, 2020); ESSA Pharma Inc (Director · Since at least Oct 1, 2020); Kezar Life Sciences, Inc. (Director · Since at least Jun 25, 2019); Kineta Inc. (Director · Jun 27, 2019 – Jun 29, 2020 · Past); Atreca Inc (Director · Jun 19, 2019 – Jun 13, 2023 · Past); Five Prime Therapeutics Inc (Director · Jun 10, 2019 – Apr 16, 2021 · Past); Tocagen Inc (Director · May 29, 2019 – Oct 4, 2019 · Past); Immune Design Corp (Director · Apr 2, 2019 – Apr 2, 2019 · Past)
Director · Apr 22, 2021 – Jan 26, 2024 · Past
Mark N Lampert
Other companies: Immunic, Inc. (Director · Since at least Feb 17, 2026); Kymera Therapeutics, Inc. (Director · Since at least Jan 11, 2023); Olema Pharmaceuticals, Inc. (Director · Since at least Jun 10, 2022); MoonLake Immunotherapeutics (Director · Since at least Apr 5, 2022); CTi Biopharma Corp (Director · Aug 9, 2022 – Jun 26, 2023 · Past)
Director · Nov 8, 2022 – Jan 25, 2024 · Past
Tran B. Nguyen
Other companies: Prothena Corporation plc (Chief Financial Officer · Since at least Mar 25, 2013); Sierra Oncology Inc (Director · Mar 18, 2016 – Jun 11, 2019 · Past); Somaxon Pharmaceuticals Inc (SVP and CFO · Apr 12, 2010 – Dec 31, 2012 · Past)
Director · Apr 22, 2021 – Jan 26, 2024 · Past
Aaron I Davis
Other companies: Tango Therapeutics, Inc. (Director · Jun 8, 2022 – Aug 11, 2023 · Past); Iteos Therapeutics Inc (Director · Jul 23, 2020 – Jun 11, 2024 · Past)
Director · Apr 22, 2021 – Jan 26, 2024 · Past
Gorjan Hrustanovic
Other companies: Kymera Therapeutics, Inc. (Director · Since at least Jun 16, 2021); Olema Pharmaceuticals, Inc. (Director · Since at least Nov 18, 2020)
Director · Apr 22, 2021 – Jan 26, 2024 · Past
Richard Paul Bryce
Other companies: enGene Therapeutics Inc. (Chief Medical Officer · Oct 31, 2023 – Nov 30, 2023 · Past); Puma Biotechnology Inc (SEE REMARKS · Jun 20, 2012 – Apr 5, 2021 · Past)
Chief Medical Officer · Apr 22, 2021 – Feb 15, 2023 · Past
Peter Radovich
Other companies: Mirum Pharmaceuticals, Inc. (PRESIDENT AND COO · Since at least May 10, 2022)
Director · Jun 1, 2022 – Jan 26, 2024 · Past
Josephine BrucePrincipal Fin. & Acc. Officer · Jun 1, 2023 – Aug 9, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Rain Oncology Inc.